A member of the U.S. biosecurity panel that recently lifted its objections to the publication of two controversial bird flu studies has slammed the way the decision was reached, saying the meeting held to reconsider the issue was “one-sided” and designed to produce the eventual outcome.
Office of Strategic Communication